{
    "id": 25752,
    "fullName": "ANXA1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "ANXA1 over exp indicates an over expression of the Anxa1 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 301,
        "geneSymbol": "ANXA1",
        "terms": [
            "ANXA1",
            "ANX1",
            "LPC1"
        ]
    },
    "variant": "over exp",
    "createDate": "11/17/2016",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9303,
            "approvalStatus": "Phase III",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a retrospective analysis of a Phase III trial, ERBB2 (HER2) positive breast cancer patients with over expression of ANXA1 demonstrated a decreased survival benefit to Herceptin (trastuzumab) compared to treated ERBB2 (HER2) positive breast cancer patients with decreased expression of ANXA1 (PMID: 27172896).",
            "molecularProfile": {
                "id": 26814,
                "profileName": "ANXA1 over exp"
            },
            "therapy": {
                "id": 947,
                "therapyName": "Trastuzumab",
                "synonyms": null
            },
            "indication": {
                "id": 60079,
                "name": "Her2-receptor positive breast cancer",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 7065,
                    "pubMedId": 27172896,
                    "title": "Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27172896"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26814,
            "profileName": "ANXA1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}